Oct 11 Trevena Inc's opioid injection
for managing acute pain failed to win the backing of an advisory
panel to the Food and Drug Administration on Thursday, against
the backdrop of opioid addiction in the United States reaching
The U.S. Food and Drug Administration said on Tuesday it seized more than a thousand pages of documents from Juul Labs related to the company's sales and marketing practices after a surprise inspection, the latest clampdown on e-cigarette companies. | Video
Pfizer Inc Chief Executive Officer Ian Read will hand over the reins of the largest U.S. drugmaker to veteran insider Albert Bourla in January, after eight years at the helm, in the backdrop of increased scrutiny over drug pricing.
(Reuters Health) - The commonly used painkiller diclofenac may be linked with an increased risk of heart problems, a large Danish study suggests.
(Reuters Health) - One in three teen drivers in the U.S. text while driving, new survey data suggests. And the number may be higher in states where teens start driving at younger ages.
(Reuters Health) - Teenagers who smoke or who binge on alcohol have signs of artery damage by age 17, a recent study shows.
Eli Lilly & Co's Elanco Animal Health unit expects its initial public offering to raise up to $1.45 billion, betting on increased appetite among investors for animal health companies.
(Reuters Health) - People with advanced cases of nonalcoholic fatty liver disease (NAFLD) may need to be watched for liver cancer, a large U.S. study suggests.
(Reuters Health) - Three out of four women who suffer the severe form of morning sickness that afflicted the Duchess of Cambridge do not experience it in subsequent pregnancies, according to a Finnish study.
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs. | Video